Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research - United States
doi 10.1158/0008-5472.can-12-0658
Full Text
Open PDFAbstract
Available in full text
Date
September 4, 2012
Authors
Publisher
American Association for Cancer Research (AACR)